ABBV vs HLI · P/E 81, rev $16.99B vs P/E 22, rev $2.62B
AbbVie Inc (ABBV) versus Houlihan Lokey Inc (HLI) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Houlihan Lokey Inc (HLI) is a capital markets company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported HLI revenue for 2026-03-31 was $2.62B. Net income was $425.7M. Revenue was up 9.5% from 2025-03-31 to 2026-03-31. HLI currently screens at market cap $9.62B and trailing P/E 22.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HLI currently screens at market cap $9.62B and trailing P/E 22.4.
Not investment advice. Open the ABBV and HLI stock pages for the full models.
Not investment advice.